No connection

Search Results

ANDE

NEUTRAL
$70.74 Live
The Andersons, Inc. · NASDAQ
Target $73.33 (+3.7%)
$31.03 52W Range $71.54
Overview AI Snowflake Price Valuation Profitability Growth Health Peers Insiders

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Mar 14, 2026
Market cap
$2.4B
P/E
25.35
ROE
8.3%
Profit margin
0.9%
Debt/Equity
0.75
Dividend yield
1.13%

AI Analysis

AI-powered fundamental assessment

Confidence
72%
The Andersons, Inc. (ANDE) exhibits mixed signals across the Advanced Deterministic Scorecard: a Piotroski F-Score of 4/9 indicates weak financial health, while the absence of an Altman Z-Score raises concern about default risk. The stock trades near its intrinsic value of $82.31 but at a premium to the Graham Number of $48.28, suggesting high growth expectations are priced in. Despite strong earnings growth (51.4% YoY) and a recent surge in EPS (142.9% Q/Q), revenue has declined sharply (-18.8% YoY), signaling underlying business headwinds. Insider selling activity and a bearish technical trend further temper optimism.

Key Strengths

Strong earnings growth (51.4% YoY) and recent Q/Q EPS surge (+142.9%) indicate operational recovery or one-time gains
Forward P/E of 12.59 suggests market expects improved profitability despite current high trailing P/E
Analyst consensus is strong_buy with a target price of $73.33, implying upside potential
Graham Number ($48.28) and intrinsic value ($82.31) provide a clear value framework, with the latter suggesting upside if growth is sustainable
Historical earnings surprise average of 20.14% over last 4 quarters reflects consistent beat potential

Key Risks

Piotroski F-Score of 4/9 indicates weak financial health, signaling potential issues in profitability, leverage, or cash flow
Revenue declined 18.8% YoY, which is concerning for a consumer defensive stock and contradicts earnings growth
Insider selling activity (2 transactions, $0.18M) with no buys suggests internal skepticism
Technical trend is bearish (10/100), and price is near 52-week high ($71.54), limiting near-term upside
Lack of Altman Z-Score and missing financials (cash, debt, FCF) prevent full health assessment; high debt/equity (0.75) and low quick ratio (0.45) are red flags
AI Fair Value Estimate
Based on comprehensive analysis
$82.31
+16.4% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
54
Moderate
Value
65
Future
78
Past
55
Health
42
Dividend
30
AI Verdict
Neutral
Key drivers: Strong earnings growth and analyst optimism, Weak financial health per Piotroski F-Score, Revenue decline contradicts earnings momentum, High valuation relative to Graham Number, Bearish technical and insider signals
Confidence
72%
Value
65/100

Ref P/E, PEG, Graham Number

Positives
  • Intrinsic value ($82.31) exceeds current price ($70.74), suggesting undervaluation if growth is sustainable
  • Forward P/E (12.59) is attractive compared to trailing P/E (25.35) and sector average (33.06)
Watchpoints
  • Current price trades at 1.91x Price/Book and 0.22x Price/Sales, which are low but may reflect poor fundamentals
  • Graham Number ($48.28) is significantly below current price, indicating premium pricing
Future
78/100

Ref Growth rates

Positives
  • 51.4% YoY earnings growth and 49.6% Q/Q earnings growth suggest strong momentum
  • Recent EPS surprise of +31.1% and average surprise of 20.14% over last 4 quarters indicate consistent beat potential
  • Forward P/E of 12.59 implies market expects sustained profitability improvement
Watchpoints
  • Revenue growth is sharply negative (-18.8% YoY), which undermines earnings sustainability
  • No PEG ratio available, limiting growth-adjusted valuation analysis
Past
55/100

Ref Historical trends

Positives
  • Historical earnings surprise average of 20.14% over last 4 quarters shows strong execution
  • Multiple quarters with EPS surprises exceeding 50% (e.g., +82.6%, +132.0%) indicate potential for volatility
Watchpoints
  • Significant earnings misses in past (e.g., -79.1%, -53.2%, -325.8%) suggest inconsistency
  • Revenue and earnings have shown high volatility, with large swings between quarters
Health
42/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Debt/Equity of 0.75 is below sector average (1.72), indicating moderate leverage
  • Current ratio of 1.41 is above 1.0, suggesting basic liquidity
Watchpoints
  • Piotroski F-Score of 4/9 indicates weak financial health, with potential issues in profitability, cash flow, or leverage
  • Quick ratio of 0.45 is very low, indicating poor short-term liquidity
  • Missing Altman Z-Score raises bankruptcy risk concerns; no Z-Score available for distress assessment
Dividend
30/100

Ref Yield, Payout

Positives
  • Dividend yield of 1.13% is modest but stable
  • Payout ratio of 28.14% is conservative and sustainable
Watchpoints
  • Dividend strength score of 25/100 indicates weak dividend quality
  • No 5-year average yield or ex-dividend date data, limiting reliability

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$70.74
Analyst Target
$73.33
Upside/Downside
+3.7%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for ANDE and closest competitors.

Updated 2026-03-13
AND
The Andersons, Inc.
Primary
5Y
+169.1%
3Y
+81.2%
1Y
+75.4%
6M
+77.4%
1M
+2.4%
1W
+10.4%
CHE
The Chefs' Warehouse, Inc.
Peer
5Y
+87.0%
3Y
+73.2%
1Y
+19.8%
6M
+6.2%
1M
-6.7%
1W
-0.3%
PRD
Perdoceo Education Corporation
Peer
5Y
+231.0%
3Y
+195.5%
1Y
+46.4%
6M
+4.5%
1M
+6.0%
1W
+2.7%
COT
Coty Inc.
Peer
5Y
-75.5%
3Y
-79.7%
1Y
-52.0%
6M
-41.5%
1M
+18.1%
1W
+2.5%
CCU
Compañía Cervecerías Unidas S.A.
Peer
5Y
-23.1%
3Y
-21.1%
1Y
-25.4%
6M
-6.3%
1M
+5.4%
1W
-6.9%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
25.35
Forward P/E
12.59
PEG Ratio
N/A
P/B Ratio
1.91
P/S Ratio
0.22
EV/Revenue
0.3
EV/EBITDA
12.35
Market Cap
$2.4B

Profitability

Profit margins and return metrics

Profit Margin 0.87%
Operating Margin 3.72%
Gross Margin 6.47%
ROE 8.26%
ROA 2.12%

Growth

Revenue and earnings growth rates

Revenue Growth -18.8%
Earnings Growth +51.4%
Q/Q Revenue Growth N/A
Q/Q Earnings Growth +49.6%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.75
Moderate
Current Ratio
1.41
Good
Quick Ratio
0.45
Poor
Cash/Share
$3.07

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-05
$N/A
2026-02-17
$2.04
+31.1% surprise
2025-11-04
$0.84
+82.6% surprise
2025-08-04
$0.24
-53.2% surprise

Consumer Defensive Sector Comparison

Comparing ANDE against 170 companies in the Consumer Defensive sector (9 bullish, 60 neutral, 101 bearish)
P/E Ratio
25.35
This Stock
vs
37.45
Sector Avg
-32.3% (Discount)
Return on Equity (ROE)
8.26%
This Stock
vs
-13.91%
Sector Avg
-159.3% (Below Avg)
Profit Margin
0.87%
This Stock
vs
-7.77%
Sector Avg
-111.2% (Weaker)
Debt to Equity
0.75
This Stock
vs
1.89
Sector Avg
-60.0% (Less Debt)
Revenue Growth
-18.8%
This Stock
vs
111.74%
Sector Avg
-116.8% (Slower)
Current Ratio
1.41
This Stock
vs
2.29
Sector Avg
-38.5% (Weaker)

Similar Companies

Peer comparison within the same industry

ANDE The Andersons, Inc.
NEUTRAL
Mkt Cap
$2.4B
P/E
25.4
ROE
8.3%
Price
$70.74
CHEF The Chefs'...
NEUTRAL
Mkt Cap
$2.4B
P/E
35.3
ROE
12.7%
Price
$59.24
 Compare with ANDE
PRDO Perdoceo...
BULLISH
Mkt Cap
$2.3B
P/E
15.0
ROE
16.6%
Price
$36.32
 Compare with ANDE
COTY Coty Inc.
BEARISH
Mkt Cap
$2.1B
P/E
-
ROE
-12.6%
Price
$2.42
 Compare with ANDE
CCU Compañía...
BEARISH
Mkt Cap
$2.1B
P/E
15.9
ROE
8.3%
Price
$11.45
 Compare with ANDE

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

REX ANNE G.
Officer
Sell
2026-03-04
2,624 shares · $170,988
REX ANNE G.
Officer
Stock Award
2026-03-02
1,550 shares
BOWE PATRICK E.
Director
Stock Award
2026-03-02
15,522 shares
ZIBBEL SARAH
Officer
Stock Award
2026-03-02
1,360 shares
KRUEGER WILLIAM E
Chief Executive Officer
Stock Award
2026-03-02
20,386 shares
HOELTER MICHAEL T.
Officer
Stock Award
2026-03-02
1,402 shares
WALZ BRIAN K.
Officer and Treasurer
Stock Award
2026-03-02
1,550 shares
SIMMONS MARK D
Officer
Stock Award
2026-03-02
1,503 shares
HEIDE WESTON
Officer
Stock Award
2026-03-02
1,809 shares
VALENTINE BRIAN A.
Chief Financial Officer
Stock Award
2026-03-02
6,876 shares
VALENTINE BRIAN A.
Chief Financial Officer
Stock Award
2026-03-02
169 shares
REX ANNE G.
Officer
Stock Award
2026-03-02
37 shares
BOWE PATRICK E.
Director
Stock Award
2026-03-02
468 shares
ZIBBEL SARAH
Officer
Stock Award
2026-03-02
23 shares
KRUEGER WILLIAM E
Chief Executive Officer
Stock Award
2026-03-02
443 shares
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
STRONG_BUY
3 analysts
BMO Capital
2026-02-19
Maintains
Outperform Outperform
Benchmark
2026-02-05
init
Buy
BMO Capital
2025-12-10
up
Market Perform Outperform
BMO Capital
2025-11-06
Maintains
Market Perform Market Perform

Past News Coverage

Recent headlines mentioning ANDE from our newsroom.

Newest → oldest
Back to All Stocks
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI Chat
Markets
Profile